Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994

被引:74
作者
Stiller, CA [1 ]
Eatock, EM [1 ]
机构
[1] Univ Oxford, Dept Paediat, Childhood Canc Res Grp, Oxford OX2 6HJ, England
关键词
leukaemia; survival; referral patterns; clinical trials;
D O I
10.1136/adc.81.3.202
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aims-To document survival rates after acute lymphoblastic leukaemia (ALL) during the era of modern chemotherapy, to assess effects of prognostic factors at presentation, and to investigate the relation of survival to patterns of organisation of care. Patients-From a population based series of 5078 children diagnosed in the UK during 1980-94, 4988 remained for analysis after exclusion of nine children ascertained from death certificates alone and 81 who received no antileukaemia treatment. Main outcome measures-Actuarial survival rates. Results-Between 1980-84 and 1990-94, the proportion of children treated at paediatric oncology centres rose from 77% to 89%, and the proportion entered into national trials rose from 59% to 82%. Each of age, sex, white blood count, immunophenotype, and Down's syndrome status had a highly significant effect on survival. Five year survival improved from 67% in 1980-84 to 81% in 1990-94, a 42% reduction in the risk of death within five years of diagnosis. Survival did not differ significantly between hospitals with different numbers of new patients per year or between paediatric oncology centres and other hospitals. Children who were entered into national trials had higher survival and this difference became greater in recent years; five year survival rates for children diagnosed during 1980-84 were 70% and 64% for trial and non-trial patients, respectively; in 1990-94 the rates were 84% and 68% for trial and non-trial patients, respectively. Conclusions-Survival after ALL continues to improve. Nearly 50 children/year diagnosed during 1990-94 survived who would have died a decade before. Survival does not vary systematically with place of treatment but is higher for children entered into national trials.
引用
收藏
页码:202 / 208
页数:7
相关论文
共 21 条
[1]   Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non Hodgkin's lymphoma (B-NHL) - results of the UKCCSG 9003 protocol [J].
Atra, A ;
Gerrard, M ;
Hobson, R ;
Imeson, JD ;
Ashley, S ;
Pinkerton, CR .
BRITISH JOURNAL OF CANCER, 1998, 77 (12) :2281-2285
[2]   Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X [J].
Chessells, JM ;
Harrison, G ;
Lilleyman, JS ;
Bailey, CC ;
Richards, SM .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (04) :945-951
[3]   RISK ANALYSIS IN ACUTE LYMPHOBLASTIC-LEUKEMIA - PROBLEMS AND PITFALLS [J].
CHESSELLS, JM .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (10) :1656-1659
[4]  
CHESSELLS JM, 1994, LEUKEMIA, V8, P1275
[5]   GENDER AND TREATMENT OUTCOME IN CHILDHOOD LYMPHOBLASTIC-LEUKEMIA - REPORT FROM THE MRC UKALL TRIALS [J].
CHESSELLS, JM ;
RICHARDS, SM ;
BAILEY, CC ;
LILLEYMAN, JS ;
EDEN, OB .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (02) :364-372
[6]   INTENSIFICATION OF TREATMENT AND SURVIVAL IN ALL CHILDREN WITH LYMPHOBLASTIC-LEUKEMIA - RESULTS OF UK MEDICAL-RESEARCH-COUNCIL TRIAL UKALL-X [J].
CHESSELLS, JM ;
BAILEY, C ;
RICHARDS, SM ;
EDEN, OB ;
BARBOR, PRH ;
BARRETT, A ;
BARTON, C ;
BROADBENT, V ;
DEMPSEY, SI ;
DURRANT, J ;
EMERSON, P ;
EVANS, DIK ;
FENNELLY, JJ ;
GALTON, DAG ;
GIBSON, B ;
GRAY, R ;
HANN, IM ;
HARDISTY, RM ;
HILL, FGH ;
KERNAHAN, J ;
KING, DJ ;
LILLEYMAN, JS ;
MANN, J ;
MARTIN, J ;
MCELWAIN, TJ ;
MELLOR, ST ;
JONES, PHM ;
OAKHILL, A ;
PETO, J ;
RADFORD, M ;
REES, JKH ;
STEVENS, RF ;
SUMMERFIELD, GP ;
THOMPSON, EN .
LANCET, 1995, 345 (8943) :143-148
[7]   RESULTS OF MEDICAL-RESEARCH-COUNCIL CHILDHOOD LEUKEMIA TRIAL UKALL-VIII (REPORT TO THE MEDICAL-RESEARCH-COUNCIL ON BEHALF OF THE WORKING PARTY ON LEUKEMIA IN CHILDHOOD) [J].
EDEN, OB ;
LILLEYMAN, JS ;
RICHARDS, S ;
SHAW, MP ;
PETO, J .
BRITISH JOURNAL OF HAEMATOLOGY, 1991, 78 (02) :187-196
[8]   Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI) [J].
Hann, IM ;
Richards, SM ;
Eden, OB ;
Hill, FGH .
LEUKEMIA, 1998, 12 (08) :1249-1255
[9]   MACHO CHEMOTHERAPY FOR STAGE-IV B-CELL LYMPHOMA AND B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA OF CHILDHOOD [J].
HANN, IM ;
EDEN, OB ;
BARNES, J ;
PINKERTON, CR .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (03) :359-364
[10]   PROGNOSIS OF DOWNS-SYNDROME WITH ACUTE-LEUKEMIA [J].
LEVITT, GA ;
STILLER, CA ;
CHESSELLS, JM .
ARCHIVES OF DISEASE IN CHILDHOOD, 1990, 65 (02) :212-216